Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Eir
  6. /
  7. Avantor Inc.
EIR
•Avantor Inc.•August 12, 2019

Avantor Inc. – FDA EIR, Aug 12, 2019

Record Details

An FDA surveillance inspection of Avantor Inc.'s Phillipsburg, NJ facility, a manufacturer, repacker, and tester of human Active Pharmaceutical Ingredients (APIs), was conducted from August 6-12, 2019. The inspection was guided by regulatory frameworks including CPGM 7356.002, CPGM 7356.002F, and ICH Q7 Good Manufacturing Practices for APIs, which ensure product quality and safety.

The inspection identified two primary concerns. Firstly, the firm was not performing annual product reviews for APIs manufactured at the facility, failing to follow their established procedure (SOP PRO-00049). This omission hinders a comprehensive assessment of product quality trends. Secondly, the warehouse, which stores raw materials, intermediates, and finished APIs, lacked consistent temperature and humidity monitoring. This is critical as some stored products, like Galactose and Sodium Phosphate, have specified "room temperature" stability conditions, and the absence of monitoring, along with no prior temperature mapping study, could compromise product integrity.

While no FDA-483 was issued, management acknowledged these observations during the close-out meeting, indicating an understanding of the need to address these issues. Minor facility maintenance concerns, such as broken floors and an open roof, were corrected during the inspection. The expectation is that Avantor Inc. will implement corrective actions to ensure compliance with quality system requirements and proper environmental controls for API storage.

Company
Avantor Inc.
Inspection date
August 12, 2019
Product type
drugs
Office
New Jersey District Office
People
  • Stacey Calderone (recipient)
  • Rose L. Jean-Mary
  • Tonia F. Bernard
  • Chairoji Raviwong (company_representative)
  • John Townsend Baker (other)
View Company Profile

ID · f9502bee-a41e-4590-afa4-981f9515b7da

Violation Codes2
FD&C Act 501(a)(2)(B)21 CFR 211

Full citation text and observation details available on the Dashboard.

Other documents for Avantor Inc.
  • 483 - 2025-05-27May 27, 2025
  • EIR - 2018-08-03August 3, 2018

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Avantor Inc.
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.